N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide

C96H97Cl3F3N25O4S — CID 159201473

IUPACN-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide
SMILESCC(=O)NC1CCC(c2nc(-c3ccccc3C(F)(F)F)nc(Nc3n[nH]c4ccccc34)c2C)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1C1CCC(NS(C)(=O)=O)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCNCC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCOCC1
InChIInChI=1S/C27H27F3N6O.C25H27ClN6O2S.C22H22ClN7.C22H21ClN6O/c1-15-23(17-11-13-18(14-12-17)31-16(2)37)32-25(19-7-3-5-9-21(19)27(28,29)30)33-24(15)34-26-20-8-4-6-10-22(20)35-36-26;1-15-22(16-11-13-17(14-12-16)32-35(2,33)34)27-24(18-7-3-5-9-20(18)26)28-23(15)29-25-19-8-4-6-10-21(19)30-31-25;1-14-19(26-21-16-7-3-5-9-18(16)28-29-21)25-20(15-6-2-4-8-17(15)23)27-22(14)30-12-10-24-11-13-30;1-14-19(25-21-16-7-3-5-9-18(16)27-28-21)24-20(15-6-2-4-8-17(15)23)26-22(14)29-10-12-30-13-11-29/h3-10,17-18H,11-14H2,1-2H3,(H,31,37)(H2,32,33,34,35,36);3-10,16-17,32H,11-14H2,1-2H3,(H2,27,28,29,30,31);2-9,24H,10-13H2,1H3,(H2,25,26,27,28,29);2-9H,10-13H2,1H3,(H2,24,25,26,27,28)
InChIKeyKPIQLXNRWQVBMY-UHFFFAOYSA-N
MW1860.42 g/mol
LogP20.25
Rot. Bonds19

About N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide

N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide (PubChem CID 159201473) has the molecular formula C96H97Cl3F3N25O4S and a molecular weight of 1860.42 g/mol. Its IUPAC name is N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide.

Molecular Properties

Compound NameN-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide
PubChem CID159201473
Molecular FormulaC96H97Cl3F3N25O4S
Molecular Weight1860.42 g/mol
Exact Mass1857.69
IUPAC NameN-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide
SMILESCC(=O)NC1CCC(c2nc(-c3ccccc3C(F)(F)F)nc(Nc3n[nH]c4ccccc34)c2C)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1C1CCC(NS(C)(=O)=O)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCNCC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCOCC1
InChIInChI=1S/C27H27F3N6O.C25H27ClN6O2S.C22H22ClN7.C22H21ClN6O/c1-15-23(17-11-13-18(14-12-17)31-16(2)37)32-25(19-7-3-5-9-21(19)27(28,29)30)33-24(15)34-26-20-8-4-6-10-22(20)35-36-26;1-15-22(16-11-13-17(14-12-16)32-35(2,33)34)27-24(18-7-3-5-9-20(18)26)28-23(15)29-25-19-8-4-6-10-21(19)30-31-25;1-14-19(26-21-16-7-3-5-9-18(16)28-29-21)25-20(15-6-2-4-8-17(15)23)27-22(14)30-12-10-24-11-13-30;1-14-19(25-21-16-7-3-5-9-18(16)27-28-21)24-20(15-6-2-4-8-17(15)23)26-22(14)29-10-12-30-13-11-29/h3-10,17-18H,11-14H2,1-2H3,(H,31,37)(H2,32,33,34,35,36);3-10,16-17,32H,11-14H2,1-2H3,(H2,27,28,29,30,31);2-9,24H,10-13H2,1H3,(H2,25,26,27,28,29);2-9H,10-13H2,1H3,(H2,24,25,26,27,28)
InChIKeyKPIQLXNRWQVBMY-UHFFFAOYSA-N
XLogP20.25
TPSA368.97 Ų
H-Bond Donors11
H-Bond Acceptors23
Rotatable Bonds19
Heavy Atoms132
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001860.42
LogP ≤ 520.25
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1023

Analyze N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[4-(2-chlorophenyl)-6-cyclohexylpyrimidin-2-yl]-5-fluoro-1H-indazol-3-amine;N-[4-(2-chlorophenyl)-6-piperidin-1-ylpyrimidin-2-yl]-5-fluoro-1H-indazol-3-amine;N-[4-(2-chlorophenyl)-6-piperidin-1-ylpyrimidin-2-yl]-1H-indazol-3-amine;N-[4-cyclohexyl-6-[2-(trifluoromethyl)phenyl]pyrimidin-2-yl]-5-fluoro-1H-indazol-3-amine
CID 157974937
benzyl 4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]piperazine-1-carboxylate;N-[2-(2-chlorophenyl)-5-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-1H-indazol-3-amine;1-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperazin-1-yl]ethanone;N-[5-methyl-6-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]-1H-indazol-3-amine
CID 158258132
1-[2-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)pyrimidin-4-yl]piperidin-1-yl]ethanone;N-[2-(2-chlorophenyl)-6-[2-(methylperoxysulfanylamino)ethyl]pyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-6-(1-methylsulfonylpiperidin-2-yl)pyrimidin-4-yl]-1H-indazol-3-amine;1-[4-[6-(1H-indazol-3-ylamino)-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]piperidin-1-yl]ethanone
CID 159453100
N-[2-[6-(1H-indazol-3-ylamino)-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide;N-[2-[6-(1H-indazol-3-ylamino)-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[6-(4-methylperoxysulfanylpiperazin-1-yl)-2-(2-methylphenyl)pyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-1H-indazol-3-amine
CID 161489363
6-N-(2-aminoethyl)-5-N-(1H-indazol-3-yl)-3-[2-(trifluoromethyl)phenyl]-1,2,4-triazine-5,6-diamine;5-(2-chlorophenyl)-6-N-[2-(dimethylamino)ethyl]-3-N-(1H-indazol-3-yl)-1,2,4-triazine-3,6-diamine;6-N-[2-(dimethylamino)ethyl]-3-N-(1H-indazol-3-yl)-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazine-3,6-diamine;N-[6-methyl-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazin-3-yl]-1H-indazol-3-amine
CID 161811895
N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]cyclopropanecarboxamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]methanesulfonamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-3-methylbutanamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide
CID 157627747
bis[bis(phosphanyl)phosphanyl]-(diphosphanyl)phosphane;bis[bis(phosphanyl)phosphanyl]-phosphanylphosphane;4-[2-[1-(2-chloro-6-methylquinazolin-4-yl)piperidin-2-yl]-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9-yl]morpholine;2,4-dichloro-6-methylquinazoline;methane;methanesulfonamide;N-[5-methyl-4-[2-(9-morpholin-4-yl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-2-yl)piperidin-1-yl]quinazolin-2-yl]methanesulfonamide;4-(2-piperidin-2-yl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9-yl)morpholine
CID 157678890
3-[5-[3-[4-(2-fluorophenyl)-1H-indol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-1,1-dimethylurea;N-[5-[3-[4-(2-fluorophenyl)-1H-indol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]methanesulfonamide;N-[5-[3-[4-(2-fluorophenyl)-1H-indol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-4-methylpiperazine-1-carboxamide;N-[5-[3-[4-(2-fluorophenyl)-1H-indol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-1-methylpiperidine-4-carboxamide;N-[5-[3-[4-(2-fluorophenyl)-1H-indol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide
CID 158066792
N-[5-[3-[7-(3-chlorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]cyclopropanecarboxamide;N-[5-[3-[7-(3-chlorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]methanesulfonamide;N-[5-[3-[7-(3-chlorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-4-methylpiperazine-1-carboxamide;N-[5-[3-[7-(3-chlorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-1-methylpiperidine-4-carboxamide;N-[5-[3-[7-(3-chlorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide
CID 158252177
N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]cyclopropanecarboxamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]methanesulfonamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]-1-methylpiperidine-4-carboxamide;N-[5-[3-[4-(3-chlorophenyl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]morpholine-4-carboxamide
CID 158357552
1-[(2R,5S)-4-[7-(3-amino-5-methyl-1H-indazol-4-yl)-6-chloro-2-[3-(dimethylamino)but-3-enylamino]-8-fluoroquinazolin-4-yl]-2,5-dimethylpiperazin-1-yl]prop-2-en-1-one;bis(1-[(2R,5S)-4-[7-(3-amino-5-methyl-1H-indazol-4-yl)-6-chloro-8-fluoro-2-(2-piperidin-1-ylethoxy)quinazolin-4-yl]-2,5-dimethylpiperazin-1-yl]prop-2-en-1-one);1-[(2R,5S)-4-[7-(3-amino-5-methyl-1H-indazol-4-yl)-6-chloro-8-fluoro-2-(3-pyrrolidin-1-ylbut-3-enylamino)quinazolin-4-yl]-2,5-dimethylpiperazin-1-yl]prop-2-en-1-one;1-[(2R,5S)-4-[6-chloro-2-[3-(dimethylamino)azetidin-1-yl]-7-(3-ethyl-5-methyl-2H-indazol-4-yl)-8-fluoroquinazolin-4-yl]-2,5-dimethylpiperazin-1-yl]prop-2-en-1-one
CID 159498175
5-chloro-2-N-[2-fluoro-5-methyl-4-[1-(3-piperidin-1-ylsulfonylpropyl)piperidin-4-yl]phenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;1-[2-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-2,5-dimethylphenyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-5-fluoro-2-methylphenyl]piperidin-1-yl]butan-1-one;4-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]methyl]-5-fluoro-2-methylphenyl]piperidin-1-yl]-1-morpholin-4-ylbutan-1-one
CID 160312901

Frequently Asked Questions

What is the IUPAC name of N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide?
The IUPAC name of N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide (CID 159201473) is N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide.
What is the SMILES notation for N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide?
The canonical SMILES for N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide is CC(=O)NC1CCC(c2nc(-c3ccccc3C(F)(F)F)nc(Nc3n[nH]c4ccccc34)c2C)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1C1CCC(NS(C)(=O)=O)CC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCNCC1.Cc1c(Nc2n[nH]c3ccccc23)nc(-c2ccccc2Cl)nc1N1CCOCC1.
What is the InChIKey of N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide?
The InChIKey is KPIQLXNRWQVBMY-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27F3N6O.C25H27ClN6O2S.C22H22ClN7.C22H21ClN6O/c1-15-23(17-11-13-18(14-12-17)31-16(2)37)32-25(19-7-3-5-9-21(19)27(28,29)30)33-24(15)34-26-20-8-4-6-10-22(20)35-36-26;1-15-22(16-11-13-17(14-12-16)32-35(2,33)34)27-24(18-7-3-5-9-20(18)26)28-23(15)29-25-19-8-4-6-10-21(19)30-31-25;1-14-19(26-21-16-7-3-5-9-18(16)28-29-21)25-20(15-6-2-4-8-17(15)23)27-22(14)30-12-10-24-11-13-30;1-14-19(25-21-16-7-3-5-9-18(16)27-28-21)24-20(15-6-2-4-8-17(15)23)26-22(14)29-10-12-30-13-11-29/h3-10,17-18H,11-14H2,1-2H3,(H,31,37)(H2,32,33,34,35,36);3-10,16-17,32H,11-14H2,1-2H3,(H2,27,28,29,30,31);2-9,24H,10-13H2,1H3,(H2,25,26,27,28,29);2-9H,10-13H2,1H3,(H2,24,25,26,27,28).
What are the key properties of N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide?
N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide has a molecular weight of 1860.42 g/mol, XLogP of 20.25, 19 rotatable bonds, 11 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[2-(2-chlorophenyl)-6-(1H-indazol-3-ylamino)-5-methylpyrimidin-4-yl]cyclohexyl]methanesulfonamide;N-[2-(2-chlorophenyl)-5-methyl-6-morpholin-4-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[2-(2-chlorophenyl)-5-methyl-6-piperazin-1-ylpyrimidin-4-yl]-1H-indazol-3-amine;N-[4-[6-(1H-indazol-3-ylamino)-5-methyl-2-[2-(trifluoromethyl)phenyl]pyrimidin-4-yl]cyclohexyl]acetamide is sourced from PubChem (CID 159201473), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).